Dergiler / Acta Medica Nicomedia / 2026 / Cilt: 8 Sayı: 2

ROSMARİNİK ASİTİN İNSAN KOLON KANSERİNDE OTOFAJİK ETKİSİ

AUTOPHAGIC EFFECT OF ROSMANIRIC ACID ON HUMAN COLON CANCER

İlkay Çorumluoğlu(ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-5125-302X
Ebru Alimogullari(ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-9557-3631
Sayfa
126–132
Yayın Tarihi
2025-06-30
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Bulgular: LPS hasarı oluşturulan grupta kontrol grubuna göre otofajik protein ifadesi yüksek bulunurken, LPS+RA verilen grupta diğer gruplar ile karşılaştırıldığında istatistiksel olarak anlamlı bulundu (p<0,05).

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Amaç: Kolon kanseri en agresif kanser türüdür ve tedavilerin yetersiz olmasından kaynaklı ileri aşamalarda kötü prognoz ile karakterizedir.
📊
Temel Bulgular & Veri:Rosmarinik asit kolon, pankreas, prostat, karaciğer ve multipl miyelom dahil olmak üzere çeşitli kanserlerdeki lezyonlara karşı etkili olduğu kanıtlanmıştır.
💡
Sonuç & Katkı:Bulgular: LPS hasarı oluşturulan grupta kontrol grubuna göre otofajik protein ifadesi yüksek bulunurken, LPS+RA verilen grupta diğer gruplar ile karşılaştırıldığında istatistiksel olarak anlamlı bulundu (p<0,05).
🔬Tür:Deneysel Tarla Denemesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Caco-2 · Beclin-1 · p62

Özet

Amaç: Kolon kanseri en agresif kanser türüdür ve tedavilerin yetersiz olmasından kaynaklı ileri aşamalarda kötü prognoz ile karakterizedir. Rosmarinik asit kolon, pankreas, prostat, karaciğer ve multipl miyelom dahil olmak üzere çeşitli kanserlerdeki lezyonlara karşı etkili olduğu kanıtlanmıştır. Yöntem: Çalışmamızda lipopolisakkarit (LPS) ile oluşturulan hücresel hasar ve otofaji üzerine rozmanirik asitin kolon kanseri hücrelerine etkisini araştırmayı amaçladık. Çalışmamızda Caco-2 (HTB-37) insan kolon kanseri hücre hattı kullanıldı. Kontrol, LPS, RA ve LPS+RA olmak üzere 4 grup dizayn edildi. Caco-2 için 200 µg/mL RA dozu ve LPS dozu 10 μg/ml kullanılmıştır. Caco-2 hücre hatları kültüre edildikten sonra Beclin-1, p62 ve LC3 proteinlerinin hücresel lokalizasyonlarını belirlemek için immünohistokimyasal analizler gerçekleştirildi. Otofajik yolaktaki bu proteinlerin ifadesini belirlemek için western blot analizleri yapıldı. Bulgular: LPS hasarı oluşturulan grupta kontrol grubuna göre otofajik protein ifadesi yüksek bulunurken, LPS+RA verilen grupta diğer gruplar ile karşılaştırıldığında istatistiksel olarak anlamlı bulundu (p<0,05). Sonuç: Bu çalışma ile rosmarinik asitin kolon kanseri hücrelerinde otofaji yolağında önemli proteinlerin degredasyonuna karşı klinik etkilerinin tespit edilebilmesi için daha kapsamlı çalışmaların yapılması gerektiğini önermekteyiz.

Abstract

Objective: Colon cancer is the most aggressive type of cancer and is characterized by a inefficient prognosis in advanced stages due to inadequate treatment. Rosmarinic acid has been shown to be effective against lesions in various cancers, including colon, pancreatic, prostate, liver and multiple myeloma. In our study, we aimed to investigate the effect of rosmarinic acid on lipopolysaccharide (LPS)-induced cell damage and autophagy in colorectal cancer cells. Methods: The human colon cancer cell line Caco-2 (HTB-37) was used in our study. 4 groups were formed: Control, LPS, RA and LPS+RA. For Caco-2, an RA dose of 200 µg/ml and an LPS dose of 10 µg/ml were used. After the Caco-2 cell lines were cultured, immunohistochemical analyzes were performed to determine the cellular localizations of Beclin-1, p62 and LC3 proteins. Western blot analyzes were performed to determine the expression of these proteins in the autophagic pathway. Results: While autophagic protein expression was higher in the LPS-damaged group compared to the control group, it was statistically significant in the LPS+RA group compared to the other groups (p<0,05). Conclusion: In conclusion, with this study we suggest that more comprehensive studies should be conducted to determine the clinical effect of rosmarinic acid against the degradation of key proteins in the autophagy pathway in colorectal cancer cells.

Anahtar kelimeler
🔖

Bu Makaleye Atıf Yap

Çorumluoğlu, İ., Alimogullari, E. (2025). ROSMARİNİK ASİTİN İNSAN KOLON KANSERİNDE OTOFAJİK ETKİSİ. Acta Medica Nicomedia, Cilt: 8 Sayı: 2, 126–132. https://doi.org/10.53446/actamednicomedia.1589884

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (44)

  1. Wang Y, Wang C, Zhong R, Wang L, Sun L. Research progress of DNA methylation in colorectal cancer (Review). Mol Med Rep. 2024;30(3):154. doi:10.3892/mmr.2024.13278
  2. Jain SM, Nagainallur Ravichandran S, Murali Kumar M, et al. Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review. Cancer Biol Ther. 2024;25(1):2317999. doi:10.1080/15384047.2024.2317999
  3. Argilés G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, Laurent-Puig P, Quirke P, Yoshino T, Taieb J, Martinelli E, Arnold D; ESMO Guidelines Committee. Electronic address: [email protected]. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(10):1291-1305. doi:10.1016/j.annonc.2020.06.022
  4. Fasano M, Pirozzi M, Miceli CC, et al. TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities. Int J Mol Sci. 2024;25(13):7400. doi:10.3390/ijms25137400
  5. Deshaies RJ. Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy. BMC Biol. 2014;12:94. doi:10.1186/s12915-014-0094-0
  6. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546-58. doi:10.1126/science.1235122
  7. Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009;136(5):823-37. doi:10.1016/j.cell.2009.02.024
  8. Galluzzi L, Pietrocola F, Bravo-San Pedro JM, et al. Autophagy in malignant transformation and cancer progression. EMBO J. 2015;34(7):856-80. doi:10.15252/embj.201490784
  9. Levy JM, Thorburn A. Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther. 2011;131(1):130-41. doi:10.1016/j.pharmthera.2011.03.009
  10. Fu Q, Jiang Y, Zhang D, Liu X, Guo J, Zhao J. Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signaling. Mol Cell Biochem. 2016;418(1-2):189-98. doi:10.1007/s11010-016-2746-6
  11. D'Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019;43(6):582-592. doi:10.1002/cbin.11137
  12. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19(21):5720-8. doi:10.1093/emboj/19.21.5720
  13. Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol. 2004;36(12):2503-18. doi:10.1016/j.biocel.2004.05.009
  14. Cayli S, Sahin C, Sanci TO, Nakkas H. Inhibition of p97/VCP function leads to defective autophagosome maturation, cell cycle arrest and apoptosis in mouse Sertoli cells. Theriogenology. 2020;158:196-206. doi:10.1016/j.theriogenology.2020.09.017
  15. Ji CH, Kwon YT. Crosstalk and Interplay between the Ubiquitin-Proteasome System and Autophagy. Mol Cells. 2017;40(7):441-449. doi:10.14348/molcells.2017.0115
  16. Kwon YT, Ciechanover A. The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy. Trends Biochem Sci. 2017;42(11):873-886. doi:10.1016/j.tibs.2017.09.002
  17. Ciechanover A. The unravelling of the ubiquitin system. Nat Rev Mol Cell Biol. 2015;16(5):322-4. doi:10.1038/nrm3982
  18. Vega-Rubín-de-Celis S. The Role of Beclin 1-Dependent Autophagy in Cancer. Biology (Basel). 2019;9(1):4. doi:10.3390/biology9010004
  19. Li W, Zhang L. Regulation of ATG and Autophagy Initiation. Adv Exp Med Biol. 2019;1206:41-65. doi:10.1007/978-981-15-0602-4_2
  20. Nakkas H, Ocal BG, Kipel S, et al. Ubiquitin proteasome system and autophagy associated proteins in human testicular tumors. Tissue Cell. 2021;71:101513. doi:10.1016/j.tice.2021.101513
  21. Tran S, Fairlie WD, Lee EF. BECLIN1: Protein Structure, Function and Regulation. Cells. 2021;10(6):1522. doi:10.3390/cells10061522
  22. Ngo SN, Williams DB, Head RJ. Rosemary and cancer prevention: preclinical perspectives. Crit Rev Food Sci Nutr. 2011;51(10):946-54. doi:10.1080/10408398.2010.490883. PMID: 21955093
  23. Öztürk Küp F, Koçak B, Akın AT, et al. Lipopolisakkarit’in neden olduğu bağırsak toksisitesine karşı biyosentetik gümüş nanopartiküllerin etkisi. Türk Hijyen Ve Deneysel Biyoloji Dergisi. 2020;77(3):333-342.
  24. Liu Y, Xu X, Tang H, Pan Y, Hu B, Huang G. Rosmarinic acid inhibits cell proliferation, migration, and invasion and induces apoptosis in human glioma cells. Int J Mol Med. 2021;47(5):67. doi:10.3892/ijmm.2021.4900
  25. Woottisin N, Sukprasert S, Kulsirirat T, Tharavanij T, Sathirakul K. Evaluation of the Intestinal Permeability of Rosmarinic Acid from Thunbergia laurifolia Leaf Water Extract in a Caco-2 Cell Model. Molecules. 2022;27(12):3884. doi:10.3390/molecules27123884
  26. Lin TY, Fan CW, Maa MC, Leu TH. Lipopolysaccharide-promoted proliferation of Caco-2 cells is mediated by c-Src induction and ERK activation. Biomedicine (Taipei). 2015;5(1):5. doi:10.7603/s40681-015-0005-x
  27. Cayli S, Alimogullari E, Piskin I, Bilginoglu A, Nakkas H. Effect of pioglitazone on the expression of ubiquitin proteasome system and autophagic proteins in rat pancreas with metabolic syndrome. J Mol Histol. 2021;52(5):929-942. doi:10.1007/s10735-021-10013-1
  28. Liu H, Deng R, Zhu CW, et al. Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer metastasis via co-inhition of COX-2 and PD1/PD-L1 signaling axis. Acta Pharmacol Sin. 2024;45(1):193-208. doi:10.1038/s41401-023-01158-8
  29. Huang JY, Hsu TW, Chen YR, Kao SH. Rosmarinic Acid Potentiates Cytotoxicity of Cisplatin against Colorectal Cancer Cells by Enhancing Apoptotic and Ferroptosis. Life (Basel). 2024;14(8):1017. doi:10.3390/life14081017
  30. Siegel RL, Miller KD, Sauer AG, Fedewa SA. Colorectal Cancer Statistics, 2020. 2020;70(3):145-164. doi:10.3322/caac.21601
  31. Ilhan N, Bektas I, Susam S, Ozercan IH. Protective effects of rosmarinic acid against azoxymethane-induced colorectal cancer in rats. J Biochem Mol Toxicol. 2022;36(2):e22961. doi:10.1002/jbt.22961
  32. Messeha SS, Zarmouh NO, Asiri A, Soliman KFA. Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells. Eur J Pharmacol. 2020;885:173419. doi:10.1016/j.ejphar.2020.173419
  33. Jin BR, Chung KS, Hwang S, et al. Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axis. Neoplasia. 2021;23(6):561-573. doi:10.1016/j.neo.2021.05.002
  34. Pagano K, Tomaselli S, Molinari H, Ragona L. Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms. Front Neurosci. 2020;14:619667. doi:10.3389/fnins.2020.619667
  35. Cao W, Mo K, Wei S, Lan X, Zhang W, Jiang W. Effects of rosmarinic acid on immunoregulatory activity and hepatocellular carcinoma cell apoptosis in H22 tumor-bearing mice. Korean J Physiol Pharmacol. 2019;23(6):501-508. doi:10.4196/kjpp.2019.23.6.501
  36. Doğanyiğit Z, Küp FÖ, Silici S, Deniz K, Yakan B, Atayoglu T. Protective effects of propolis on female rats' histopathological, biochemical and genotoxic changes during LPS induced endotoxemia. Phytomedicine. 2013;20(7):632-9. doi:10.1016/j.phymed.2013.01.010
  37. Samarghandian S, Azimi-Nezhad M, Farkhondeh T. Anti-Carcinogenic Effects of Carnosol-An Updated Review. Curr Drug Discov Technol. 2018;15(1):32-40. doi:10.2174/1570163814666170413121732
  38. Andersson D, Cheng Y, Duan RD. Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats. J Cancer Res Clin Oncol. 2008;134(1):101-7. doi:10.1007/s00432-007-0255-4
  39. Singletary KW, Nelshoppen JM. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and of in vivo formation of mammary DMBA-DNA adducts by rosemary extract. Cancer Lett. 1991;60(2):169-75. doi:10.1016/0304-3835(91)90224-6
  40. Singletary K, MacDonald C, Wallig M. Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett. 1996;104(1):43-8. doi:10.1016/0304-3835(96)04227-9
  41. Amagase H, Sakamoto K, Segal ER, Milner JA. Dietary rosemary suppresses 7,12-dimethylbenz(a)anthracene binding to rat mammary cell DNA. J Nutr. 1996;126(5):1475-80. doi:10.1093/jn/126.5.1475
  42. Osakabe N, Yasuda A, Natsume M, Yoshikawa T. Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis. 2004;25(4):549-57. doi:10.1093/carcin/bgh034
  43. Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005;12 Suppl 2(Suppl 2):1542-52. doi:10.1038/sj.cdd.4401765
  44. Yang L, Li P, Fu S, Calay ES, Hotamisligil GS. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010;11(6):467-78. doi:10.1016/j.cmet.2010.04.005